8-K: Premier Inc. Exceeds Expectations in Fiscal 2024, Announces Leadership Transition and Strategic Shifts

Premier, Inc. reported better-than-expected financial results for the fourth quarter and full fiscal year 2024, while also announcing a CEO transition and strategic divestitures.

Summary

• Premier, Inc. exceeded expectations for both revenue and profitability in the fourth quarter and full fiscal year 2024.
• Consolidated net revenue increased due to growth in both Supply Chain Services and Performance Services segments.
• The company's GPO retention rate was 97% and SaaS institutional renewal rate was 95%.
• The Board of Directors approved an additional $200 million share repurchase under the existing $1 billion authorization.
• Premier is divesting its majority interests in Contigo Health and S2S Global businesses.
• The Remitra business will be reported as part of the Supply Chain Services segment starting in fiscal 2025.
• Adjusted EBITDA for the full year was $445.8 million, a decrease of 8% compared to the prior year.
• Adjusted EPS for the full year was $2.36, a decrease of 2% compared to the prior year.
• Free cash flow for the year was $115.7 million, down from $264.4 million in the prior year, primarily due to tax payments related to the sale of the non-healthcare GPO operations.
• The company received a total of $723.8 million from the sale of its non-healthcare GPO operations.
• Fiscal year 2025 guidance includes total net revenue between $930 million and $1.02 billion, adjusted EBITDA between $235 million and $255 million, and adjusted EPS between $1.16 and $1.28.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to the better-than-expected results for fiscal 2024 and the share repurchase program, but it is tempered by the lower guidance for fiscal 2025 and the strategic divestitures.

Positives

• The company exceeded expectations for both revenue and profitability in the fourth quarter and full fiscal year 2024.
• Premier achieved strong member retention rates with a 97% GPO retention rate and a 95% SaaS institutional renewal rate.
• The company secured significant new business, including five new supply chain co-management agreements and a major GPO contract with AllSpire Health Partners.
• Premier is expanding its reach into adjacent markets, with double-digit growth in its applied sciences and clinical decision support businesses.
• The company is returning capital to shareholders through share repurchases and dividends.
• The company has a strong financial position with a flexible balance sheet and no outstanding balance on its revolving credit facility.
• The company is leveraging its digital supply chain capabilities to ensure timely payment and accurate reporting for manufacturers.

Negatives

• Adjusted EBITDA for the full year decreased by 8% compared to the prior year.
• Adjusted EPS for the full year decreased by 2% compared to the prior year.
• Free cash flow decreased significantly due to tax payments related to the sale of the non-healthcare GPO operations.
• The company expects lower revenue in both Supply Chain Services and Performance Services segments in fiscal 2025.
• The company anticipates an increase in aggregate blended member fee share in the GPO, which will negatively impact profitability.
• The company is excluding the financial contributions from Contigo Health and S2S Global in its fiscal 2025 guidance.
• The company expects the first quarter of fiscal 2025 to be the lowest point for the year in terms of revenue and profitability.

Risks

• The company faces risks related to the divestiture of its majority interests in Contigo Health and S2S Global businesses.
• The company's financial performance is subject to changes in member fee share in the GPO.
• The company's revenue and profitability are impacted by the timing of new bookings and revenue recognition in the Performance Services segment.
• The company's free cash flow is subject to fluctuations due to tax payments and other factors.
• The company's future performance is subject to risks and uncertainties, many of which are outside of its control.
• The company's guidance does not include the impact of any significant acquisitions or share repurchases.

Future Outlook

The company expects lower revenue in both Supply Chain Services and Performance Services segments in fiscal 2025, with total net revenue between $930 million and $1.02 billion, adjusted EBITDA between $235 million and $255 million, and adjusted EPS between $1.16 and $1.28. The company anticipates an increase in aggregate blended member fee share in the GPO to the low 60% range for fiscal 2025.

Management Comments

• Michael Alkire, Premier President and CEO, stated that the fourth-quarter and full-year results exceeded expectations.
• Alkire highlighted the company's expanding role as a strategic partner for providers, manufacturers, and payers.
• Craig McKasson, Chief Administrative and Financial Officer, expressed gratitude for his career at Premier and his contributions to the company's success.
• McKasson noted that the company is focused on returning capital to stockholders and will continue to evaluate opportunities for organic growth and acquisitions.
• Alkire mentioned that the company is seeing strong demand for its co-sourcing and co-management capabilities.

Industry Context

The announcement reflects a trend in the healthcare industry towards consolidation and the need for integrated services and standardization. Premier's focus on technology enablement and data-driven solutions aligns with the industry's move towards more efficient and cost-effective healthcare delivery. The company's expansion into adjacent markets also indicates a broader trend of healthcare companies diversifying their offerings.

Comparison to Industry Standards

• Premier's GPO retention rate of 97% is strong compared to industry averages, indicating high customer satisfaction and loyalty.
• The company's SaaS institutional renewal rate of 95% also demonstrates the value of its technology offerings.
• The company's adjusted EBITDA margin of mid 20s for fiscal 2025 is in line with other healthcare technology and services companies.
• The company's free cash flow as a percentage of adjusted EBITDA is expected to be 45% to 55% for fiscal 2025, which is a reasonable target for a company in this sector.
• The company's decision to divest non-core assets is a common strategy for companies looking to focus on their core competencies and improve profitability.
• The company's share repurchase program is a common way for companies to return capital to shareholders and increase shareholder value.

Management Changes

Stakeholder Impact

• Shareholders will benefit from the share repurchase program and dividends.
• Employees will be impacted by the leadership transition and strategic shifts.
• Customers will benefit from the company's focus on technology enablement and data-driven solutions.
• Suppliers will be impacted by the company's digital supply chain capabilities.
• Creditors will be impacted by the company's financial performance and capital deployment decisions.

Next Steps

• The company will continue to execute its strategy to technology-enable better healthcare performance and a smarter supply chain.
• The company will continue to return value to stockholders through share repurchases and dividends.
• The company will continue the process to divest non-core assets, S2S Global and Contigo Health.
• The company will finalize additional member renewals during fiscal 2025.
• The company will continue to assess the remaining $400 million under the share repurchase authorization.
• The company will evaluate opportunities to further invest in organic growth and assess potential acquisitions.

Key Dates

Keywords

healthcare, supply chain, GPO, technology, performance services, EBITDA, share repurchase, divestiture, AI, digital supply chain, member retention, co-management